Michelle A Elliott (Michelle Elliott)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Topics

Acute Myeloid Leukemia

Diffusion Weighted Imaging

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

Genetics in medicine : official journal of the American College of Medical Genetics

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Naseema Gangat, Amritpal Singh, Rimal Ilyas, Giuseppe Gaetano Loscocco, Michelle A Elliott, Kebede H Begna, Animesh D Pardanani, Ayalew Tefferi
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies. American journal of hematology (2024)
Ayalew Tefferi, Animesh D Pardanani, Aref A Al-Kali, Hassan Alkhateeb, McCullough Kristen, Mirinal S Patnaik, William J Hogan, Kebede H Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Katalin Kelemen, Attilio Orazi, Dong Chen, Kaaren K Reichard
Mast cell cytomorphology and treatment outcome in mast cell leukemia. American journal of hematology (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
John McGlothlin, Jithma Abeykoon, Eyad Al-Hattab, Aneel A Ashrani, Michelle A Elliott, C Christopher Hook, Animesh D Pardanani, Rajiv Pruthi, Meera Sridharan, Alexandra Wolanskyj, Rachelle Rouse, Ronald Go
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia. American journal of hematology (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Animesh D Pardanani, Ayalew Tefferi, Aref A Al-Kali, Mirinal S Patnaik, William J Hogan, Kebede H Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Attilio Orazi, Katalin Kelemen, Kaaren K Reichard, Dong Chen
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome. American journal of hematology (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Natasha Szuber, Michelle A Elliott, Ayalew Tefferi
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management. American journal of hematology 97 (4) (2022)
Amritpal Singh, Aref A Al-Kali, James M Foran, Michelle A Elliott, Kebede H Begna, Talha Badar, Nandita Khera, Farah Fleti, Maymona Abdelmagid, Kareen K Reichard, Rhett P Ketterling, Animesh D Pardanani, Naseema Gangat, Ayalew Tefferi
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting. American journal of hematology 97 (10) (2022)
Faiqa Farrukh, Naseema Gangat, Mithun Vinod Shah, Mark R Litzow, Michelle A Elliott, Kebede H Begna, Christopher C Hook, Ayalew Tefferi, Animesh D Pardanani
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience. American journal of hematology 97 (4) (2022)
Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Vinod Shah, Mirinal S Patnaik, Michelle A Elliott, William J Hogan, Mark R Litzow, Christopher C Hook, Abhishek A Mangaonkar, David Viswanatha, Dong Chen, Animesh D Pardanani, Rhett P Ketterling, Courtney D D DiNardo, Tapan Mahendra Kadia, Farhad Ravandi, Koji Sasaki, Kebede H Begna
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. American journal of hematology 97 (9) (2022)
Naseema Gangat, Amritpal Singh, Natasha Szuber, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Valerio De Stefano, Tiziano Barbui, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Kebede H Begna, Naseema Gangat, Aref Al-Kali, Mark R Litzow, William J Hogan, Mirinal S Patnaik, Animesh D Pardanani, C Christopher Hook, Alexandra P Wolanskyj, Michelle A Elliott, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy. American journal of hematology 96 (4) (2021)
Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, Aref Al-Kali, James M Foran, Jeanne M Palmer, Hassan Alkhateeb, Michelle A Elliott, Curtis A Hanson, Animesh D Pardanani, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 96 (7) (2021)
Erika Morsia, McCullough Kristen, Maansi Joshi, Joselle Madonna Cook, Hassan B Alkhateeb, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, William Hogan, Mark R Litzow, Mithun Shah, Animesh Pardanani, Mirinal S Patnaik, Ayalew Tefferi, Naseema Gangat
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients. American journal of hematology 95 (12) (2020)
Theodora Anagnostou, Ryan A Knudson, Kathryn E Pearce, Reid G Meyer, Beth A Pitel, Jess F Peterson, Linda B Baughn, Kaaren K Reichard, Rhett P Ketterling, Sara M Kloft-Nelson, Darlene L Knutson, Shakila P Khan, Naseema Gangat, Mark R Litzow, William J Hogan, Alexandra Wolanskyj, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Animesh Pardanani, James Foran, Mithun Shah, Ayalew Tefferi, Hassan Alkhateeb, Kevin Halling, Vilmarie Rodriguez, Patricia T Greipp, Mirinal S Patnaik
Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia. American journal of hematology 95 (3) (2020)
Michelle A Elliott, Ayalew Tefferi
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management. American journal of hematology 93 (4) (2019)
Natasha Szuber, Michelle A Elliott, Ayalew Tefferi
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management. American journal of hematology 95 (2) (2019)
Ayalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, Kebede H Begna, Mirinal S Patnaik, Michelle A Elliott, C Christopher Hook, Alexandra P Wolanskyj, Curtis A Hanson, Rhett P Ketterling, Animesh Pardanani, Naseema Gangat
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American journal of hematology 94 (1) (2018)
Kebede H Begna, Walid Ali, Naseema Gangat, Michelle A Elliott, Aref Al-Kali, Mark R Litzow, C Christopher Hook, Alexandra P Wolanskyj, William J Hogan, Mirinal S Patnaik, Animesh Pardanani, Darci L Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status. American journal of hematology 93 (12) (2018)
John Ogden, Jennifer Yui, Walid Ali, Mythri Mudireddy, Aref Al-Kali, Mirinal S Patnaik, Naseema Gangat, Michelle A Elliott, William Hogan, Christopher Hook, Alexandra Wolanskyj-Spinner, Animesh Pardanani, Hector Villarraga, Mark Litzow, Ayalew Tefferi, Kebede H Begna
Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia. American journal of hematology 93 (6) (2018)
Pedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, A Keith Stewart, Gianrico Farrugia, Cloann G Schultz, Carolyn R Rohrer Vitek, Janet E Olson, Jennifer L St Sauver, Veronique L Roger, Mark A Parkulo, Iftikhar J Kullo, Wayne T Nicholson, Michelle A Elliott, John L Black, Richard M Weinshilboum
Multidisciplinary model to implement pharmacogenomics at the point of care. Genetics in medicine : official journal of the American College of Medical Genetics 19 (4) (2016)